Additionally, the 36-month beta value for MAIA is 0.21. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MAIA is 19.77M and currently, short sellers hold a 3.35% ratio of that float. The average trading volume of MAIA on November 18, 2024 was 124.43K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MAIA) stock’s latest price update
MAIA Biotechnology Inc (AMEX: MAIA) has experienced a rise in its stock price by 6.10 compared to its previous closing price of 2.13. However, the company has seen a fall of -22.34% in its stock price over the last five trading days. businesswire.com reported 2024-11-05 that CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the SITC 39th Annual Meeting.
MAIA’s Market Performance
MAIA Biotechnology Inc (MAIA) has seen a -22.34% fall in stock performance for the week, with a -10.14% decline in the past month and a -23.39% plunge in the past quarter. The volatility ratio for the week is 16.27%, and the volatility levels for the past 30 days are at 10.85% for MAIA. The simple moving average for the past 20 days is -16.44% for MAIA’s stock, with a -17.81% simple moving average for the past 200 days.
MAIA Trading at -17.77% from the 50-Day Moving Average
After a stumble in the market that brought MAIA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.27% of loss for the given period.
Volatility was left at 10.85%, however, over the last 30 days, the volatility rate increased by 16.27%, as shares sank -12.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.71% lower at present.
During the last 5 trading sessions, MAIA fell by -22.34%, which changed the moving average for the period of 200-days by +45.81% in comparison to the 20-day moving average, which settled at $2.70. In addition, MAIA Biotechnology Inc saw 93.16% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAIA starting from Luput Cristian, who purchase 22,133 shares at the price of $2.51 back on Nov 01 ’24. After this action, Luput Cristian now owns 389,483 shares of MAIA Biotechnology Inc, valued at $55,554 using the latest closing price.
CHAOUKI STEVEN M, the Director of MAIA Biotechnology Inc, purchase 22,133 shares at $2.51 during a trade that took place back on Nov 01 ’24, which means that CHAOUKI STEVEN M is holding 111,024 shares at $55,554 based on the most recent closing price.
Stock Fundamentals for MAIA
The total capital return value is set at -3.26. Equity return is now at value -1188.16, with -319.37 for asset returns.
Currently, EBITDA for the company is -20.18 million with net debt to EBITDA at 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.56.
Conclusion
In conclusion, MAIA Biotechnology Inc (MAIA) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
